Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanouil Papasavvas

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Plos Medicine|January 5, 2005
Randomized, controlled trial of therapy interruption in chronic HIV-1 infectionEmmanouil Papasavvas, Jay R Kostman, Karam Mounzer, et al.
Journal of Virology|January 1, 2010
Inability of plasmacytoid dendritic cells to directly lyse HIV-infected autologous CD4+ T cells despite induction of tumor necrosis factor-related apoptosis-inducing ligandJihed Chehimi, Emmanouil Papasavvas, Costin Tomescu, et al.
AIDS (London, England)|December 31, 2008
Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patientsEmmanouil Papasavvas, Maxwell Pistilli, Griffin Reynolds, et al.
The Pediatric Infectious Disease Journal|May 10, 2011
Increased microbial translocation in ≤ 180 days old perinatally human immunodeficiency virus-positive infants as compared with human immunodeficiency virus-exposed uninfected infants of similar ageEmmanouil Papasavvas, Livio Azzoni, Andrea Foulkes, et al.
Carcinogenesis|October 27, 2018
Gene expression profiling informs HPV cervical histopathology but not recurrence/relapse after LEEP in ART-suppressed HIV+HPV+ womenEmmanouil Papasavvas, Andrew V Kossenkov, Livio Azzoni, et al.
Oncoimmunology|July 29, 2016
High-risk oncogenic HPV genotype infection associates with increased immune activation and T cell exhaustion in ART-suppressed HIV-1-infected womenEmmanouil Papasavvas, Lea F Surrey, Deborah K Glencross, et al.
AIDS (London, England)|September 28, 2012
Concurrent measures of total and integrated HIV DNA monitor reservoirs and ongoing replication in eradication trialsAngela M Mexas, Erin H Graf, Matthew J Pace, et al.
The Journal of Infectious Diseases|September 10, 2003
Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppressionEmmanouil Papasavvas, Johan K Sandberg, Richard Rutstein, et al.
AIDS (London, England)|January 24, 2020
Plasma and antibody glycomic biomarkers of time to HIV rebound and viral setpointLeila B Giron, Emmanouil Papasavvas, Livio Azzoni, et al.
Lasers in Surgery and Medicine|May 26, 2018
A preclinical model to investigate the role of surgically-induced inflammation in tumor responses to intraoperative photodynamic therapyRichard W Davis, Emmanouil Papasavvas, Astero Klampatsa, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Plos Medicine|January 5, 2005
Randomized, controlled trial of therapy interruption in chronic HIV-1 infectionEmmanouil Papasavvas, Jay R Kostman, Karam Mounzer, et al.
Journal of Virology|January 1, 2010
Inability of plasmacytoid dendritic cells to directly lyse HIV-infected autologous CD4+ T cells despite induction of tumor necrosis factor-related apoptosis-inducing ligandJihed Chehimi, Emmanouil Papasavvas, Costin Tomescu, et al.
AIDS (London, England)|December 31, 2008
Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patientsEmmanouil Papasavvas, Maxwell Pistilli, Griffin Reynolds, et al.
The Pediatric Infectious Disease Journal|May 10, 2011
Increased microbial translocation in ≤ 180 days old perinatally human immunodeficiency virus-positive infants as compared with human immunodeficiency virus-exposed uninfected infants of similar ageEmmanouil Papasavvas, Livio Azzoni, Andrea Foulkes, et al.
Carcinogenesis|October 27, 2018
Gene expression profiling informs HPV cervical histopathology but not recurrence/relapse after LEEP in ART-suppressed HIV+HPV+ womenEmmanouil Papasavvas, Andrew V Kossenkov, Livio Azzoni, et al.
Oncoimmunology|July 29, 2016
High-risk oncogenic HPV genotype infection associates with increased immune activation and T cell exhaustion in ART-suppressed HIV-1-infected womenEmmanouil Papasavvas, Lea F Surrey, Deborah K Glencross, et al.
AIDS (London, England)|September 28, 2012
Concurrent measures of total and integrated HIV DNA monitor reservoirs and ongoing replication in eradication trialsAngela M Mexas, Erin H Graf, Matthew J Pace, et al.
The Journal of Infectious Diseases|September 10, 2003
Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppressionEmmanouil Papasavvas, Johan K Sandberg, Richard Rutstein, et al.
AIDS (London, England)|January 24, 2020
Plasma and antibody glycomic biomarkers of time to HIV rebound and viral setpointLeila B Giron, Emmanouil Papasavvas, Livio Azzoni, et al.
Lasers in Surgery and Medicine|May 26, 2018
A preclinical model to investigate the role of surgically-induced inflammation in tumor responses to intraoperative photodynamic therapyRichard W Davis, Emmanouil Papasavvas, Astero Klampatsa, et al.
Pageof 6